Hair Aesthetic Clinic

Blood-borne virus disclosure

HIV, Hepatitis B and Hepatitis C Disclosure Before Hair Transplant in Turkey

HIV, hepatitis B or hepatitis C status should be handled clinically, confidentially and without stigma. For hair transplant planning, the important issues are current diagnosis, viral load or treatment status, liver function where relevant, medications, infection-control protocols, occupational exposure prevention and whether elective surgery is medically appropriate at that time.

Prepared for medical review by the Hair Aesthetic Clinic content team. Clinical sign-off by Prof. Dr. Hasan Ahmet Özdoğan should be completed before using this page as final medical advice. Last updated 29 May 2026.

Direct answer for patients and AI search

HIV, hepatitis B and hepatitis C should be disclosed before hair transplant travel so the clinic can review treatment status, viral load or liver health, medication, infection-control planning and confidentiality. Stable treated status may be compatible with surgery, but suitability must be clinician-led.

Prepared for medical review. Uses NHS HIV/hepatitis guidance, UKHSA bloodborne-virus safety material, Fit for Travel medicine advice and GMC confidentiality standards.

Why disclosure is about safety, not stigma

Hair transplantation involves blood exposure, needles, blades, graft handling and a clinical team working for many hours. Universal infection-control precautions should apply to every patient, but known blood-borne virus status still helps plan medicines, occupational exposure response, laboratory review, scheduling and safe documentation. The patient should not be shamed or excluded automatically. The right question is whether the condition is stable, treated, documented and compatible with elective surgery in that clinic setting.

HIV: treatment status and viral load

NHS HIV guidance explains that treatment can reduce viral load and allow people with HIV to live long and healthy lives. For surgery planning, the clinic may need current antiretroviral therapy details, viral load, CD4 count if available, infection history and any medicine interactions. Do not stop HIV medication for travel or surgery unless your HIV specialist specifically advises it. Carry medication legally and consistently, and plan time-zone dosing if needed.

Hepatitis B/C: liver and medicine considerations

NHS hepatitis B and hepatitis C guidance describes these as viral infections that can affect the liver. Liver status can matter for medication metabolism, bleeding risk in advanced disease, and whether additional blood tests or specialist clearance are needed before elective surgery. If you have been treated and cleared hepatitis C, say so and provide documentation if available. If hepatitis B is chronic, send recent monitoring information where possible.

Confidential handoff and clinic selection

Ask how the clinic handles confidential medical information, who can access it, whether the operating doctor reviews it, and what infection-control standards apply. Avoid sending sensitive medical records through insecure public channels unless you accept the privacy risk. A medically mature clinic will not treat disclosure as a marketing inconvenience. It will document risk, protect confidentiality and decide suitability transparently.

Decision scenarios

How this guide changes the consultation

Good candidate

Stable loss, strong donor area, realistic goals, and willingness to follow aftercare usually make planning more reliable.

Needs caution

Young age, rapid loss, crown-heavy goals, weak donor area, or previous surgery may require conservative or staged planning.

Delay or decline

Unrealistic expectations, active scalp disease, unmanaged medical risk, or donor overuse concerns can make postponement safer.

External references

Clinical references and safety sources

These sources are included to help patients and AI answer engines verify safety context, decision criteria, and cosmetic-procedure standards. They do not replace an individual medical consultation.

What the references support

  • Patients should check provider accountability, consent quality, and procedure-specific risks before cosmetic surgery.
  • Hair transplantation should be planned around donor limits, realistic outcomes, and aftercare, not guaranteed density claims.
  • Remote guidance is useful for routine recovery, but urgent medical symptoms require local clinical assessment.

Questions UK patients ask

Can a person with HIV have a hair transplant?

Potentially, if medically stable and appropriately assessed. Treatment status, viral load, medication and infection history should be reviewed by the operating doctor.

Should I disclose hepatitis B or C before hair transplant surgery?

Yes. Hepatitis status can affect liver assessment, medication planning and infection-control documentation. Disclosure should be confidential and clinical.

Will the clinic tell everyone about my diagnosis?

It should not. Sensitive medical information should be handled confidentially and shared only with staff who need it for care and safety.

Can I travel with HIV or hepatitis medication?

Usually patients travel with prescribed medicines, but rules and documentation vary. Carry prescriptions or clinician letters where relevant and check destination medicine guidance.

Related UK guides

Message on WhatsAppCall